Citigroup »

Fulcrum Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-12-31 $234k 50k 4.70
2024-09-30 $262k 75k 3.50
2024-06-30 $137k 23k 6.00
2024-03-31 $1.6M 179k 9.00
2023-12-31 $2.0M 285k 7.00
2023-09-30 $357k 89k 4.00
2023-03-31 $4.9k 1.7k 2.85
2022-12-31 $13k 1.8k 7.28
2022-09-30 $16k 1.9k 8.33
2021-12-31 $715k 40k 17.68
2021-03-31 $21k 1.7k 12.06
2020-12-31 $42k 3.6k 11.69
2020-09-30 $5.0k 687 7.28
2020-06-30 $32k 1.7k 18.42
2020-03-31 $44k 3.7k 11.96
2019-12-31 $15k 912 16.45
2019-09-30 $2.7k 239 11.36